Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 7/20 | 0.59 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.49 |
| ▸ | ABL1 | P00519 | 1/20 | 0.46 |
| ▸ | DPP4 | P27487 | 2/20 | 0.46 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | HTR3A | P46098 | 1/20 | 0.46 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.45 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.45 |
| ▸ | SYK | P43405 | 1/20 | 0.45 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.43 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.43 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16695224 | 0.83 | NOTUM (0.69) | NOTUMAKR1C3AKR1C1 | |
| SCHEMBL16695200 | 0.83 | NOTUM (0.69) | NOTUMAKR1C3AKR1C1 | |
| SCHEMBL16695072 | 0.82 | DPP4 (0.52) | NOTUMPDK2DPP4SLC6A9HTR3A | |
| SCHEMBL29604898 | 0.82 | DPP4 (0.52) | NOTUMPDK2DPP4SLC6A9HTR3A | |
| SCHEMBL16695079 | 0.82 | DPP4 (0.52) | NOTUMPDK2DPP4SLC6A9HTR3A | |
| SCHEMBL12674885 | 0.78 | NOTUM (0.50) | NOTUMPDK2MAP4K4SYK | |
| SCHEMBL19904490 | 0.78 | NOTUM (0.68) | NOTUMMAP4K4SYKAKR1C3 | |
| SCHEMBL13733384 | 0.78 | NOTUM (0.57) | NOTUMPDK2RXFP1MAP4K4SYK | |
| SCHEMBL5799831 | 0.77 | NOTUM (0.55) | NOTUMPDK2SLC6A9HTR3AAKR1C3 | |
| SCHEMBL12675626 | 0.77 | NOTUM (0.51) | NOTUMPDK2ABL1MAP4K4SYK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3063141-B1 | N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | BIOMARIN PHARM INC (US) | 2018-02-28 | — | — | EP | disclosed |